"Groundbreaking Flu Vaccine on the Horizon: Moderna's mRNA-Based Shot Set to Revolutionize Flu Prevention In a major breakthrough, the US Food and Drug Administration (FDA) has given the green light to Moderna's revolutionary mRNA-based flu vaccine, marking the first of its kind to receive approval. This innovative vaccine utilizes a cutting-edge technology that allows the body to produce a specific protein that helps to build immunity against the flu virus, rather than relying on traditional inactivated or live attenuated vaccines. As the upcoming flu season approaches, the approval of Moderna's mRNA-based flu shot brings new hope for a more effective and potentially game-changing way to protect against the flu. With its unprecedented approval, millions of Americans may soon have access to this groundbreaking vaccine, which could significantly reduce the risk of flu-related illnesses and hospitalizations."
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
